Clinical Trials Browser

Phase 2 × Locally Advanced Rectal Cancer × Immune Checkpoint Inhibitors × Clear all

NCT06304987 2024-03-19

Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and PCSK9 Inhibitor for pMMR/MSS Locally Advanced Mid-low Rectal Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Locally Advanced Rectal Cancer

NCT05845268 2023-05-06

Total Neoadjuvant Therapy Combined With Tislelizumab for Local Advanced of Middle and Low Rectal Cancer

Phase 2 Unknown

Gastrointestinal

Locally Advanced Rectal Cancer